Cargando…

Delayed hyper-enhancement cardiac magnetic resonance provides incremental prognostic value in patients with cardiac amyloidosis

Detalles Bibliográficos
Autores principales:	Austin, Bethany A, Flamm, Scott, Rodriguez, E Rene, Tan, Carmela, Tang, WH Wilson, Taylor, David O, Starling, Randall C, Desai, Milind Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860843/ http://dx.doi.org/10.1186/1532-429X-11-S1-O65

Ejemplares similares

Delayed hyper-enhancement cardiac magnetic resonance imaging is more accurate than other noninvasive parameters in diagnosis of patients with endomyocardial biopsy positive cardiac amyloidosis
por: Austin, Bethany A, et al.
Publicado: (2009)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Incremental value of cardiac magnetic resonance in the characterization of unselected patients referred to exclude arrhythmogenic right ventricular cardiomyopathy
por: Roghi, Alberto, et al.
Publicado: (2009)

Impaired aortic distensibility determined by magnetic resonance imaging in patients with different bicuspid aortic valve phenotypes
por: Boonyasirinant, Thananya, et al.
Publicado: (2009)

Analysis of disease progression in patients with transthyretin cardiac amyloidosis
por: Gilmore, Julian D, et al.
Publicado: (2015)

Implantable cardioverter defibrillator implantation and degree of left ventricular scarring predict survival in patients with severe ischemic cardiomyopathy
por: Kwon, Deboarh H, et al.
Publicado: (2011)

Stress myocardial perfusion imaging by cardiac magnetic resonance provides strong prognostic value to cardiac events in patients with diabetes
por: Coelho-Filho, Otavio R, et al.
Publicado: (2011)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

Combined stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance provides robust prognostic information to cardiac events
por: Coelho-Filho, Otavio, et al.
Publicado: (2011)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
por: Quarta, Candida C, et al.
Publicado: (2015)

End systolic volume and scar burden are incremental and independent predictors of survival in patients with severe ischemic cardiomyopathy
por: Kwon, Deborah, et al.
Publicado: (2012)

Incremental diagnostic role of cardiac MRI in young-middle aged patients with high-grade atrio-ventricular block
por: Baritussio, Anna, et al.
Publicado: (2016)

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major
por: Kirk, Paul, et al.
Publicado: (2009)

Multi-modality imaging in cardiac ATTR amyloidosis: agreement between echocardiography, MRI and DPD-scintigraphy
por: Eliahou, Ludivine, et al.
Publicado: (2015)

DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis
por: Akinboboye, Olakunle, et al.
Publicado: (2015)

LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
por: Fontana, Marianna, et al.
Publicado: (2015)

Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
por: Maceira, Alicia M, et al.
Publicado: (2008)

Delayed Diagnosis of Cardiac Amyloidosis Secondary to Multiple Myeloma
por: Qatanani, Ahmad, et al.
Publicado: (2021)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Cardiac magnetic resonance in acute rheumatic fever
por: Sepulveda, Diana Lamprea, et al.
Publicado: (2013)

Myocardium area at risk measured with delayed enhancement after scar remodelling compared with T2-weighted cardiac magnetic resonance imaging
por: Lønborg, Jacob T, et al.
Publicado: (2011)

A case series of cardiac amyloidosis patients supported by continuous‐flow left ventricular assist device
por: Randhawa, Varinder K., et al.
Publicado: (2021)

Cardiac magnetic resonance circumferential strain predicts myocardial fibrosis in DMD-associated cardiac disease
por: Hor, Kan N, et al.
Publicado: (2013)

A case of cardiac sarcoidosis mimicking cardiac amyloidosis on cardiovascular magnetic resonance
por: Takemura, Kazunori, et al.
Publicado: (2018)

Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
por: Agibetov, Asan, et al.
Publicado: (2021)

Cardiac Amyloidosis
por: Elbdri, Salah, et al.
Publicado: (2021)

Impaired cardiac growth and function in children and adolescents after heart transplantation assessed by cardiac magnetic resonance
por: Latus, Heiner, et al.
Publicado: (2016)

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis
por: Gillmore, Julian D, et al.
Publicado: (2015)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis
por: Agha, Ali M., et al.
Publicado: (2021)

Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis
por: Dohy, Zsofia, et al.
Publicado: (2022)

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
por: Miller, Christopher A, et al.
Publicado: (2014)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
por: Donnelly, Joseph P., et al.
Publicado: (2020)

Delayed enhancement cardiac magnetic resonance imaging predicts future arrhythmic events in primary prevention ICD candidates irrespective of ischemic or non-ischemic etiology
por: Gao, Peng, et al.
Publicado: (2011)

Impact of Cardiac Magnetic Resonance (CMR) on utilization of Implantable-Cardioverter-Defibrillators (ICD) for primary prophylaxis of sudden cardiac death
por: Ertel, Andrew, et al.
Publicado: (2013)

Atrial delayed enhancement is associated with the severity of diastolic dysfunction in cardiac amyloidosis
por: Pozo, Eduardo, et al.
Publicado: (2013)

Double Delayed Enhancement: Concomitant Cardiac Amyloidosis and Acute Coronary Embolism
por: Ahmed, Talha, et al.
Publicado: (2021)

Catastrophic Cardiac Amyloidosis
por: Panduranga, Prashanth, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_hftuo3vu9mbi8dlqg22cdt4ojj